About Medicure

We have an unwavering focus on delivering safe, efficacious and cost-effective medicines that benefit patients, healthcare providers and shareholders.

Medicure is a pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics for the U.S. market. Medicure strives to become a leading specialty pharmaceutical company in the U.S. market by improving people’s lives through our growing product portfolio of acute cardiovascular products and innovative commercial model. Our commitment to service, partnership and integrity are what sets us apart.

What's New

Latest Investors Presentation

Medicure Inc. is based in Winnipeg, Canada and publicly traded on the Toronto Stock Exchange Venture under the symbol MPH.

Latest Press Releases

Stay up to date with the latest press releases about our company.

Connect With Us On Facebook

By connecting with us on Facebook, you’ll be the first to hear when new Medicure articles are published on our website.

Connect With Us On Twitter

By connecting with us on Twitter, you’ll be the first to hear about new Medicure publications.

Products
News
Events
Investor Info